Therapeutic Solutions International, Inc. (TSOI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 26, 2025, 9:30 AM EST
TSOI Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.01 | 0.03 | 0.02 | 0.09 | 0.25 | 0.03 |
Cash & Short-Term Investments | 0.01 | 0.03 | 0.02 | 0.09 | 0.25 | 0.03 |
Cash Growth | -89.76% | 50.93% | -80.40% | -62.71% | 854.74% | 17.92% |
Receivables | 0.02 | 0.02 | 0.03 | 0.02 | 0 | 0 |
Inventory | 0.02 | 0.02 | 0.04 | 0.04 | 0.01 | 0.01 |
Prepaid Expenses | 0.46 | 0.02 | 0.21 | 0.96 | 0.08 | 0.09 |
Restricted Cash | - | - | 0.01 | 0.01 | 0.01 | 0.01 |
Total Current Assets | 0.5 | 0.09 | 0.31 | 1.12 | 0.35 | 0.13 |
Property, Plant & Equipment | 0.47 | 0.5 | 0.28 | 0.32 | 0.06 | 0.01 |
Other Intangible Assets | 2.48 | 2.7 | 3 | 0.13 | 0.14 | 0.15 |
Other Long-Term Assets | 0.15 | 0 | 0.01 | 0.15 | 0.05 | 0.02 |
Total Assets | 3.6 | 3.29 | 3.61 | 1.72 | 0.6 | 0.31 |
Liabilities
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 0.42 | 0.4 | 0.41 | 0.4 | 0.31 | 0.34 |
Accrued Expenses | 0.57 | 0.54 | 0.53 | 0.49 | 0.59 | 0.51 |
Short-Term Debt | 0.82 | 0.75 | 1.05 | 1.04 | 0.98 | 0.98 |
Current Portion of Long-Term Debt | 0 | 0 | 0 | 0 | - | - |
Current Portion of Leases | 0.03 | 0.02 | 0.01 | 0.03 | 0.02 | 0.01 |
Other Current Liabilities | - | 0.18 | 0.2 | 0.53 | 0.44 | 0.52 |
Total Current Liabilities | 1.84 | 1.9 | 2.21 | 2.5 | 2.35 | 2.35 |
Long-Term Debt | 0 | 0.01 | 0.01 | 0.02 | - | - |
Long-Term Leases | 0.08 | 0.11 | - | 0.01 | 0.03 | - |
Total Liabilities | 1.92 | 2.01 | 2.22 | 2.52 | 2.38 | 2.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 5.06 | 3.8 | 2.62 | 2.31 | 2.23 | 1.61 |
Additional Paid-In Capital | 18.51 | 17.67 | 16.66 | 10.9 | 7.04 | 5.18 |
Retained Earnings | -22.31 | -20.33 | -18.16 | -13.99 | -11.03 | -8.83 |
Comprehensive Income & Other | -0.02 | -0.02 | 0.11 | -0.02 | -0.02 | - |
Total Common Equity | 1.24 | 1.13 | 1.22 | -0.8 | -1.78 | -2.04 |
Minority Interest | 0.44 | 0.16 | 0.16 | - | - | - |
Shareholders' Equity | 1.68 | 1.28 | 1.39 | -0.8 | -1.78 | -2.04 |
Total Liabilities & Equity | 3.6 | 3.29 | 3.61 | 1.72 | 0.6 | 0.31 |
Additional Metrics
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 0.93 | 0.89 | 1.08 | 1.1 | 1.04 | 0.98 |
Net Cash (Debt) | -0.92 | -0.86 | -1.06 | -1 | -0.79 | -0.96 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 5,123 | 4,230 | 2,734 | 2,505 | 2,244 | 1,657 |
Total Common Shares Outstanding | 5,057 | 3,803 | 2,617 | 2,311 | 2,234 | 1,615 |
Working Capital | -1.34 | -1.81 | -1.9 | -1.38 | -2 | -2.21 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
Tangible Book Value | -1.24 | -1.58 | -1.78 | -0.93 | -1.92 | -2.18 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Land | 0.35 | 0.35 | 0.24 | 0.24 | - | - |
Machinery | 0.07 | 0.07 | 0.07 | 0.07 | 0.02 | 0.02 |